FDA Inspection 1203309 — Frontage Laboratories, Inc.
The FDA completed an inspection of Frontage Laboratories, Inc. on March 31, 2023 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 31, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)
Additional Details
Bioanalytical BA/BE